Literature DB >> 15071053

Performance of a commercial, type-specific enzyme-linked immunosorbent assay for detection of herpes simplex virus type 2-specific antibodies in Ugandans.

Oliver Laeyendecker1, Charla Henson, Ronald H Gray, Ruby H-N Nguyen, Bobbi Jo Horne, Maria J Wawer, David Serwadda, Noah Kiwanuka, Rhoda Ashley Morrow, Wayne Hogrefe, Thomas C Quinn.   

Abstract

Two hundred forty-eight human immunodeficiency virus (HIV)-positive and 496 HIV-negative subjects in Uganda were tested by HerpeSelect herpes simplex virus type 2 enzyme-linked immunosorbent assay (ELISA) and Western blotting to optimize the ELISA for use in this population. A higher index cutoff value was required for optimal sensitivity and specificity, and overall performance of the assay was not affected by HIV status.

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15071053      PMCID： PMC387547          DOI： 10.1128/JCM.42.4.1794-1796.2004

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  13 in total

1.  Probability of HIV-1 transmission per coital act in monogamous, heterosexual, HIV-1-discordant couples in Rakai, Uganda.

Authors:  R H Gray; M J Wawer; R Brookmeyer; N K Sewankambo; D Serwadda; F Wabwire-Mangen; T Lutalo; X Li; T vanCott; T C Quinn
Journal:  Lancet       Date:  2001-04-14       Impact factor: 79.321

2.  Evaluation of an enzyme immunoassay system for measuring herpes simplex virus (HSV) type 1-specific and HSV type 2-specific IgG antibodies.

Authors:  H E Prince; C E Ernst; W R Hogrefe
Journal:  J Clin Lab Anal       Date:  2000       Impact factor: 2.352

3.  Genital herpes and public health: addressing a global problem.

Authors:  L Corey; H H Handsfield
Journal:  JAMA       Date:  2000-02-09       Impact factor: 56.272

Review 4.  Herpes simplex virus infections.

Authors:  R J Whitley; B Roizman
Journal:  Lancet       Date:  2001-05-12       Impact factor: 79.321

5.  Typing of clinical herpes simplex virus type 1 and type 2 isolates with monoclonal antibodies.

Authors:  J A Liljeqvist; B Svennerholm; T Bergström
Journal:  J Clin Microbiol       Date:  1999-08       Impact factor: 5.948

6.  Detection of herpes simplex virus type 2-specific immunoglobulin G antibodies in African sera by using recombinant gG2, Western blotting, and gG2 inhibition.

Authors:  Wayne Hogrefe; Xin Su; James Song; Rhoda Ashley; Lilly Kong
Journal:  J Clin Microbiol       Date:  2002-10       Impact factor: 5.948

7.  Comparison of Western blot (immunoblot) and glycoprotein G-specific immunodot enzyme assay for detecting antibodies to herpes simplex virus types 1 and 2 in human sera.

Authors:  R L Ashley; J Militoni; F Lee; A Nahmias; L Corey
Journal:  J Clin Microbiol       Date:  1988-04       Impact factor: 5.948

Review 8.  Genital herpes simplex virus infections: clinical manifestations, course, and complications.

Authors:  L Corey; H G Adams; Z A Brown; K K Holmes
Journal:  Ann Intern Med       Date:  1983-06       Impact factor: 25.391

9.  Comparison of the Western immunoblot assay and a glycoprotein G enzyme immunoassay for detection of serum antibodies to herpes simplex virus type 2 in patients with AIDS.

Authors:  S Safrin; A Arvin; J Mills; R Ashley
Journal:  J Clin Microbiol       Date:  1992-05       Impact factor: 5.948

10.  Human immunodeficiency virus acquisition associated with genital ulcer disease and herpes simplex virus type 2 infection: a nested case-control study in Rakai, Uganda.

Authors:  David Serwadda; Ronald H Gray; Nelson K Sewankambo; Fred Wabwire-Mangen; Michael Z Chen; Thomas C Quinn; Tom Lutalo; Noah Kiwanuka; Godfrey Kigozi; Fred Nalugoda; Mary P Meehan; Rhoda Ashley Morrow; Maria J Wawer
Journal:  J Infect Dis       Date:  2003-10-28       Impact factor: 5.226
View more
  43 in total

1.  Sero-prevalence of herpes simplex type 2 virus (HSV-2) and HIV infection in Kampala, Uganda.

Authors:  Edith Nakku-Joloba; Fred Kambugu; Julius Wasubire; Joshua Kimeze; Robert Salata; Jeffrey M Albert; Alfred Rimm; Christopher Whalen
Journal:  Afr Health Sci       Date:  2014-12       Impact factor: 0.927

2.  Gender differences in the prevalence of sexually transmitted infections and genital symptoms in an urban setting in southern India.

Authors:  S Panchanadeswaran; S C Johnson; K H Mayer; A K Srikrishnan; S Sivaran; C E Zelaya; V F Go; S Solomon; M E Bentley; D D Celentano
Journal:  Sex Transm Infect       Date:  2006-06-06       Impact factor: 3.519

3.  Sensitivity and specificity of herpes simplex virus-2 serological assays among HIV-infected and uninfected urban Ugandans.

Authors:  J Lingappa; E Nakku-Joloba; A Magaret; D Friedrich; J Dragavon; F Kambugu; M Joloba; C Whalen; R Coombs; C Celum; R Ashley Morrow
Journal:  Int J STD AIDS       Date:  2010-09       Impact factor: 1.359

4.  The epidemiology of herpes simplex virus type-2 infection among married women in Mysore, India.

Authors:  Purnima Madhivanan; Karl Krupp; Varalakshmi Chandrasekaran; Chitra Karat; Anjali Arun; Jeffrey D Klausner; Arthur L Reingold
Journal:  Sex Transm Dis       Date:  2007-11       Impact factor: 2.830

5.  Performance of focus ELISA tests for HSV-1 and HSV-2 antibodies among university students with no history of genital herpes.

Authors:  Hayley D Mark; Joy P Nanda; Jessica Roberts; Anne Rompalo; Johan H Melendez; Jonathan Zenilman
Journal:  Sex Transm Dis       Date:  2007-09       Impact factor: 2.830

6.  Improved performance of enzyme-linked immunosorbent assays and the effect of human immunodeficiency virus coinfection on the serologic detection of herpes simplex virus type 2 in Rakai, Uganda.

Authors:  Jordyn L Gamiel; Aaron A R Tobian; Oliver B Laeyendecker; Steven J Reynolds; Rhoda Ashley Morrow; David Serwadda; Ronald H Gray; Thomas C Quinn
Journal:  Clin Vaccine Immunol       Date:  2008-03-05

7.  Herpes simplex virus type 2 antibody detection performance in Kisumu, Kenya, using the Herpeselect ELISA, Kalon ELISA, Western blot and inhibition testing.

Authors:  J S Smith; R C Bailey; D J Westreich; I Maclean; K Agot; J O Ndinya-Achola; W Hogrefe; R A Morrow; S Moses
Journal:  Sex Transm Infect       Date:  2008-10-27       Impact factor: 3.519

8.  Herpes simplex virus type-2 assay specificity and male circumcision to reduce herpes simplex virus type-2 acquisition.

Authors:  Aaron A R Tobian; Godfrey Kigozi; Maria J Wawer; David Serwadda; Thomas C Quinn; Ronald H Gray
Journal:  AIDS       Date:  2013-01-02       Impact factor: 4.177

9.  Performance of HerpeSelect and Kalon assays in detection of antibodies to herpes simplex virus type 2.

Authors:  Jérôme LeGoff; Philippe Mayaud; Gérard Gresenguet; Helen A Weiss; Khonde Nzambi; Eric Frost; Jacques Pepin; Laurent Belec
Journal:  J Clin Microbiol       Date:  2008-04-02       Impact factor: 5.948

10.  Comparison of focus HerpesSelect and Kalon HSV-2 gG2 ELISA serological assays to detect herpes simplex virus type 2 antibodies in a South African population.

Authors:  Sinéad Delany-Moretlwe; Ute Jentsch; Helen Weiss; Jocelyn Moyes; Rhoda Ashley-Morrow; Wendy Stevens; Philippe Mayaud
Journal:  Sex Transm Infect       Date:  2009-10-16       Impact factor: 3.519
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.